3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Solid Tumors With High Expression of Nectin4
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Precancerous Conditions
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Carcinoma In Situ
1
Interventions
pembrolizumab
2
atezolizumab
2
Paclitaxel
2
Carboplatin
2
veliparib
1
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
entrectinib
1
cobimetinib
1
alectinib
1
Whole Genome Sequencing
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Taxes
1
Surveys and Questionnaires
1
Specimen Handling
1
Sequence Analysis, RNA
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
HhAntag691
1
Genetic Testing
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Erlotinib Hydrochloride
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Unknown Primary
×
Immunohistochemistry
×
1 year
×
Clear all
No trials found.